Otofarma SpAMIL:OTO -0.71%16 Net Margin % is 4.59% as of Dec. 2024, which is 4% above its 10-year median of 4.40. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 817 Medical Devices & Instruments companies, Otofarma SpA ranks better than 56.43% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Otofarma SpA's Net Income for the
six
months ended in Dec. 2024 was €0.70 Mil. Otofarma SpA's Revenue for the
six
months ended in Dec. 2024 was €15.20 Mil. Therefore, Otofarma SpA's net margin for the quarter that ended in Dec. 2024 was 4.59%.
The historical rank and industry rank for Otofarma SpA's Net Margin % or its related term are showing as below:
MIL:OTO'
s Net Margin % Range Over the Past 10 Years
Min: 4.2 Med: 4.4 Max: 4.59
Current: 4.59
MIL:OTO's Net Margin % is ranked better than 56.43% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs MIL:OTO: 4.59
Otofarma SpA (MIL:OTO) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Otofarma SpA Net Margin % Related Terms
Otofarma SpA Net Margin % Historical Data
* Premium members only.
The historical data trend for Otofarma SpA's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otofarma SpA Net Margin % Chart
Otofarma SpA Annual Data
Trend
Dec23
Dec24
Net Margin %
4.20
4.59
Otofarma SpA Semi-Annual Data
Dec23
Dec24
Net Margin %
4.20
4.59
MIL:OTO vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Otofarma SpA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Otofarma SpA Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Otofarma SpA's Net Margin % distribution charts can be found below:
* The bar in red indicates where Otofarma SpA's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otofarma SpA (MIL:OTO) has a Net Margin % of 4.59% as of Dec. 2024. Net margin is the ratio of total net income to net sales. View historical data on Otofarma SpA and its competitors. This is near median its historical median of 4.40. Over the past decade, Otofarma SpA's Net Margin % has ranged from 4.20 to 4.59. According to the industry distribution chart, Otofarma SpA ranks #356 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 43.6%.
Is Otofarma SpA's Net Margin % too high?
Otofarma SpA's current Net Margin % of 4.59% is near median its 10-year median of 4.40. Over the past 10 years, this metric has ranged from a low of 4.20 to a high of 4.59. The Medical Devices & Instruments industry median Net Margin % is 2.05. Otofarma SpA's value of 4.59% is 123.9% above this industry median. Based on the distribution chart, Otofarma SpA ranks #356 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Otofarma SpA ranks #356 out of 817 companies for Net Margin %. This puts Otofarma SpA in the upper half of its industry. The industry median Net Margin % is 2.05. Otofarma SpA's value of 4.59% is 123.9% above this benchmark. Historically, Otofarma SpA's own Net Margin % has ranged from 4.20 to 4.59 over the past decade. While the company's 10-year median is 4.40 vs. the industry median of 2.05, Otofarma SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Otofarma SpA's current Net Margin % of 4.59% is 123.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Otofarma SpA and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Otofarma SpA's current Net Margin % is 4.59%, which is near median its own 10-year median of 4.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Net Margin % of 4.59%. The current Net Margin % is 4.59%, which is near median its 10-year median of 4.40 and 123.9% above the Medical Devices & Instruments industry median of 2.05. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Net Margin % is 4.59% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score
Get the complete analysis for MIL:OTO
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:OTO has been successfully added to your 